Spero Therapeutics sperotherapeutics.com


Public list: Pharma Startups (4732) Google In Healthcare (60)

Spero Therapeutics is a global multi-asset clinical-stage biopharmaceutical company dedicated to developing a novel and highly differentiated pipeline of antibacterials focused on unmet needs of patients with drug-resistant bacterial infections. Spero is advancing two lead programs in parallel, SPR741 and SPR994. SPR741, also called Potentiator, is a platform approach to combination therapy to treat serious and life-threatening multidrug-resistant Gram-negative infections, such as Enterobacteria...Show all

Spero Therapeutics is a global multi-asset clinical-stage biopharmaceutical company dedicated to developing a novel and highly differentiated pipeline of antibacterials focused on unmet needs of patients with drug-resistant bacterial infections. Sper...Show all

Company (IPO / Went public)

Phone: 857-242-1600

Fax:

675 Massachusetts Avenue
14th Floor
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Spero Therapeutics $193.9M Nov 2, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Spero Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Google VenturesCorporate VentureMountain View, California, United StatesSeries C
Atlas VentureVenture CapitalCambridge, Massachusetts, United StatesSeries C, Series B, Series A, Seed VC - II, Seed VC
Lundbeckfond VenturesVenture CapitalCopenhagen East, DenmarkSeries C, Series B, Series A
MRL VenturesCorporate VentureCambridge, Massachusetts, United StatesSeries C, Series B, Series A
CARB-XPublic-Private PartnershipBoston, Massachusetts, United StatesGrant
See all 12 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)